Loading...

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Diffuse large B-cell lymphoma (DLBCL) is stratified into prognostically favorable germinal center B-cell (GCB)–like and unfavorable activated B-cell (ABC)–like subtypes based on gene expression signatures. In this study, we analyzed 893 de novo DLBCL patients treated with R-CHOP (rituximab, cyclopho...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hu, Shimin, Xu-Monette, Zijun Y., Tzankov, Alexander, Green, Tina, Wu, Lin, Balasubramanyam, Aarthi, Liu, Wei-min, Visco, Carlo, Li, Yong, Miranda, Roberto N., Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W. L., Zhao, Xiaoying, van Krieken, J. Han, Huang, Qin, Huh, Jooryung, Ai, Weiyun, Ponzoni, Maurilio, Ferreri, Andrés J. M., Zhou, Fan, Slack, Graham W., Gascoyne, Randy D., Tu, Meifeng, Variakojis, Daina, Chen, Weina, Go, Ronald S., Piris, Miguel A., Møller, Michael B., Medeiros, L. Jeffrey, Young, Ken H.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3709650/
https://ncbi.nlm.nih.gov/pubmed/23449635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-10-460063
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!